Award
NIH Reporter #1R21CA297629-01A1
Co-targeting IGF-1R and Glutaminase in Ewing Sarcoma
Recipient
Not specified
Award Amount
$391,186.00
Ceiling
$391,186.00
Awarded
July 10, 2025
Identifier
1R21CA297629-01A1
Award for research on co-targeting IGF-1R and glutaminase in Ewing Sarcoma, funded by the National Cancer Institute.
Description
The project aims to investigate the co-targeting of IGF-1R and glutaminase as a therapeutic approach for Ewing Sarcoma. The project involves genetic and pharmacologic studies using cell line and patient-derived xenograft models. The project is funded by the National Cancer Institute under the NIH.